Public goods and externalities: A research agenda for public health economics

Journal of Public Health Management and Practice

Volumn 13, Issue 2, 2007, Pages 227-232

  Carande Kulis, Vilma G ^a,b,c   Getzen, Thomas E ^d,e   Thacker, Stephen B ^f  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Office of the Chief Science Officer   (United States)

^c CDC Prevention Effectiveness and Health Economics Program   (United States)

^d TEMPLE UNIVERSITY   (United States)

^e International Health Economics Association (IHEA)   (United States)

^f CDC Office of Workforce and Career Development

Author keywords

Economic evaluation; Health economics; Public health

Indexed keywords

ATTITUDE TO HEALTH; DECISION MAKING; DISASTER; GOVERNMENT; GOVERNMENT REGULATION; HEALTH CARE POLICY; HEALTH ECONOMICS; HEALTH HAZARD; HEALTH PROGRAM; INFORMATION; MARKET; MEDICAL RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RESOURCE ALLOCATION; REVIEW; RISK MANAGEMENT; SOCIOECONOMICS;

EID: 33847025637     PISSN: 10784659     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124784-200703000-00024     Document Type: Review

References (29)

1. Mushkin S. Toward a definition of health economics. Public Health Rep. 1958;73(9):785-793.
2. Santerre SR, Neun SP. Health Economics: Theories, Insights, and Industry Studies. 3rd ed. Mason, Ohio: Thomson South-Western; 2004.
3. Elbasha EH, Fitzsimmons TD, Meltzer MI. The costs and benefits of a subtype-specific surveillance system to identify Escherichia coli O157:H7 outbreaks. Emerg Infect Dis. 2000;6:293-297.
4. Bridges CB, Thompson W, Meltzer MI, et al. Efficacy and cost benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA. 2000;284:1655-1663.
5. Griffin SO, Jones K, Tomar SL. An economic evaluation of community water fluoridation. J Public Health Dent. 2001;61(2):78-86.
6. Wang G, Zheng ZJ, Heath G, Macera C, Pratt M, Buchner D. Economic burden of cardiovascular disease associated with excess body weight in US adults. Am J Prev Med. 2002;23:1-6.
7. Chesson HW, Greenberg JB, Hennessy M. The cost-effectiveness of the WINGS intervention: a program to prevent HIV and sexually transmitted diseases among high risk urban women. BMC Infect Dis. 2002;2(1):24.
8. Grosse SD, Matte TD, Schwartz J, Jackson RJ. Economic gains resulting from the reduction in children's exposure to lead in the United States. Environ Health Perspect. 2002;110:563-569.
9. Gift TL, Walsh C, Haddix A, Irwin KL. A cost-effectiveness evaluation of testing and treatment of Chlamydia trachomatis infection among asymptomatic women infected with Neisseria gonorrhoeae. Sex Transm Dis. 2002;29(9):542-551.
10. Honeycutt AA, Grosse SD, Dunlap LJ, et al. Economic costs of mental retardation, cerebral palsy, hearing loss, and vision impairment. In: Altman BM, Barnatt SN, Hendershot G, Larson S, eds. Using Survey Data to Study Disability: Results from the National Health Interview Survey on Disability. Vol 3. London, UK: Elsevier; 2003:207-228.
11. Blandford JM, Gift TL. The cost-effectiveness of single-dose azrithromycin for treatment of incubating syphilis. Sex Transm Dis. 2003;30:502-508.
12. Centers for Disease Control and Prevention. Medical expenditures attributable to injuries - United States, 2000. MMWR. 2004;53(1):1-4.
13. Public Health Functions Steering Committee. The Public Health Workforce: An Agenda for the 21st Century. Washington, DC: US Department of Health and Human Services; 1994.
14. Grossman M. The human capital model. In: Culyer AJ, Newhouse JP, eds. Handbook of Health Economics. Amsterdam: Elsevier; 2000:347-408.
15. Grossman M. On the concept of health capital and demand for health. J Polit Econ. 1972;80:223-255.
16. Weisbrod BA. Collective-consumption services of individual-consumption goods. Q J Econ. 1964;78:471-477.
17. Stiglitz JE. Economics of the Public Sector. 2nd ed. New York: WW Norton and Company; 1988.
18. Cummins JD, Tennyson S. Moral hazard in insurance claiming: evidence from automobile insurance. J Risk Uncertainty. 1996;12(1):29-50.
19. Lillard LA, Panis CWA. Marital status and mortality: the role of Health. Demography. 1996;33:313-327.
20. Cheung YB. Can marital selection explain the differences in health between married and divorced people? From a longitudinal study of a British birth cohort. Public Health. 1998;112:113-117.
21. Cheung YB, Sloggett A. Health and adverse selection into marriage: evidence from a study of the 1958 British birth cohort study. Public Health. 1998;112:309-311.
22. Brockman H, Klein T. Love and death in Germany: the marital biography and its effects on mortality. J Marriage Fam. 2004;66:567-581.
23. Philipson T. The world-wide growth in obesity: an economic research agenda. Health Econ. 2001;10:1-7.
24. Mercer SL, Green LW, Rosenthal AC, Husten CG, Khan LK, Dietz WH. Possible lessons from the tobacco experience for obesity control. Am J Clin Nutr. 2003;77(suppl):1073S-1082S.
25. Hayne CL, Moran PA, Ford MM. Regulating environments to reduce obesity. J Public Health Policy. 2004;25(3/4):391-407.
26. Mello MM, Rimm EB, Studdert DM. The McLawsuit: the fastfood industry and legal accountability for obesity. Health Aff. 2003;22(6):207-216.
27. Mello MM, Studdert DM, Brennan TA. Obesity - the new frontier of public health law. N Engl J Med. 2006;354(24):2601-2610.
28. Comment: Is Ronal McDonald the next Joe Camel? Regulating fast food advertisements targeting children in light of the American overweight and obesity epidemic. Conn Public Interest Law J. 2004;16:454-480.
29. Philipson TJ. The long-run growth in obesity as a function of technological change. Perspect Biol Med. 2003;46(3):S87-S107.